693.932 PEOPLE
| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Mau, Robert
University of Rostock
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (8/8 displayed)
- 2022The influence of PEGDA’s molecular weight on its mechanical properties in the context of biomedical applicationscitations
- 2021Rapid tooling for micro injection molding of micro medical devices via digital light processing
- 2020PEGDA drug delivery scaffolds manufactured with a novel hybrid AM process
- 20203D printing of frames for anti-coronavirus face shields using different processes and materials
- 20193D-printed PEGDA structure with multiple depots for advanced drug delivery systems
- 2019A Novel Hybrid Additive Manufacturing Process for Drug Delivery Systems with Locally Incorporated Drug Depots. citations
- 2019Thermomechanical properties of PEGDA in combination with different photo-curable comonomerscitations
- 2018Thermomechanical properties of PEGDA and its co-polymerscitations
Places of action
| Organizations | Location | People |
|---|
article
3D-printed PEGDA structure with multiple depots for advanced drug delivery systems
Abstract
Additive manufacturing technologies have the potential to make an important contribution to the field of personalized medicine. Besides customized implants, drug delivery systems (DDS) should be tailored to the patient’s specific needs. We developed a hybrid additive manufacturing system based on stereolithography and inkjet printing to generate DDS with selectively incorporated depots of active pharmaceutical ingredients (API) to tailor the release kinetics of the API. In this work we report on the successful proof-of-principle of 3D printing of PEGDA specimens containing depots with two different inks.